系统性红斑狼疮心包炎的患病率、临床关联与结局:多伦多狼疮诊所的观察
该观察性队列研究基于多伦多狼疮诊所1970年7月至2024年3月的数据,发现2122例SLE患者中心包炎患病率为20.16%,多见于疾病早期(中位0.51年)。多变量分析显示心包炎与较高SLEDAI-2000、抗La抗体、体质性症状相关,与皮肤受累较少相关;79.5%患者3个月内缓解,15.6%呈慢性,22.9%复发。
要点
- SLE患者心包炎患病率约20.16%,多见于疾病早期(中位0.51年)。
- 心包炎与较高SLEDAI-2000、抗La抗体、体质性症状正相关,与皮肤受累负相关。
- 多数3个月内缓解,但15.6%慢性化、22.9%复发,需长期关注。
核心结论
- 心包炎影响约五分之一的SLE患者,通常出现在疾病早期,多数3个月内缓解,但部分呈慢性或复发。
研究设计与样本
- 观察性队列研究,纳入多伦多狼疮诊所1970年7月至2024年3月的SLE患者,包括起始队列(诊断1年内入组)和现患队列。
主要发现
- 2122例SLE患者中428例(20.16%)发生心包炎,起始队列900例中205例(22.8%),现患队列1222例中223例(18.2%)。
- 心包炎中位发病时间为诊断后0.51年;170例患者中位胸痛严重程度为6/10。
- 合并心肌炎5.3%、心内膜炎1.9%、心脏压塞1.4%。
- 多变量分析显示心包炎与较高SLEDAI-2000 [1.06(1.001, 1.13)]、抗La抗体 [1.52(1.01, 2.31)]、体质性症状 [1.98(1.39, 2.81)]相关,与皮肤受累较少相关 [0.34(0.21, 0.55)]。
- 79.5%患者3个月内缓解,慢性心包炎占15.6%(中位4.6个月),复发占22.9%;未发现慢性化或复发的显著关联因素。
临床怎么用
- SLE患者应警惕心包炎,尤其在疾病早期,需评估胸痛及心脏受累情况。
- 对于心包炎患者,应监测SLEDAI-2000、抗La抗体及体质性症状,并关注慢性化或复发可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pericarditis is an important clinical feature in the classification criteria and disease activity indices in SLE. We aimed to study the prevalence, associations and outcomes of pericarditis in SLE. METHODS: This was an observational cohort study conducted at the University of Toronto Lupus Clinic (July 1970-March 2024). The prevalence of pericarditis was determined in both inception (enrolled within 1 year of diagnosis) and prevalent cohorts. The outcomes of pericarditis were defined as acute (resolution <3 months), chronic (lasting ≥3 months) and relapsing (recurrence after complete resolution). Associations with pericarditis and its outcomes were studied. RESULTS: Pericarditis was identified in 428 of 2122 patients (20.16%), 205 of 900 (22.8%) in inception and 223 of 1222 (18.2%) in the prevalent cohort. It developed early in the disease course (median 0.51 years). Among 170 patients, the median chest pain severity was 6 of 10. Associated myocarditis was observed in 5.3%, endocarditis in 1.9% and cardiac tamponade in 1.4%. Pericarditis was associated with higher SLEDAI-2000 [1.06 (1.001, 1.13)], anti-La antibodies [1.52 (1.01, 2.31)], constitutional features [1.98 (1.39, 2.81)] and less skin involvement [0.34 (0.21, 0.55)] in multivariable analysis. Most patients (79.5%) had resolution within 3 months. Chronic pericarditis occurred in 15.6% (median 4.6 months) and relapses in 22.9%. No significant associations were found for chronicity or relapse. CONCLUSION: Pericarditis affects one in five SLE patients, usually early in the disease. Most cases resolve in 3 months, but a subset experiences chronic or relapsing disease.
引用
- Mehta P, Kharouf F, Carrizo-Abarza V, et al. Prevalence, clinical associations and outcomes of pericarditis in systemic lupus erythematosus: insights from the University of Toronto Lupus Clinic. Rheumatology (Oxford). 2026. PMID: 41390927. doi:10.1093/rheumatology/keaf669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。